Skip to main content
Premium Trial:

Request an Annual Quote

Money for Medicine


Continuing on Genome Technology's look at translational medicine research for this issue, we checked into funding for this burgeoning area from NIH, where the field is a key part of the agency's roadmap. Last October, NIH launched a new consortium, funded with Clinical and Translational Science Awards and led by the National Center for Research Resources, designed to revolutionize how clinical and translational research takes place.

Twelve academic centers were chosen as the first members of the new consortium; 52 more received planning grants to help them prepare applications to become members in the future. Member institutions will receive approximately $100 million during this first year, and NIH expects that to increase to about $500 million annually by 2012, when the consortium is slated to be running at full scale with some 60 member centers.

Listed below are the 12 inaugural grants, showing PI, institution, name of the center, and award amount. Total grant amount was calculated by tallying several awards made to each investigator under the same center name.

Center Name

Frank Arnett 
University of Texas Health Science Center
Center for Clinical and Translational Sciences

Lars Berglund
University of California, Davis
Center for Clinical and Translational Sciences

Robert Califf
Duke University
Clinical Translational Science Institute

Barry Coller
Rockefeller University
Rockefeller University Center for Clinical and Translational Sciences

Garret FitzGerald
University of Pennsylvania
Institute for Translational Medicine and Therapeutics

Henry Ginsberg
Columbia University Health Sciences
Irving Institute for Clinical and Translational Research

David Guzick 
University of Rochester
University of Rochester Clinical and Translational Science Institute

Joseph McCune
University of California, San Francisco
Clinical and Translational Science Institute

Eric Orwoll
Oregon Health & Science University
Oregon Clinical and Translational Science Institute

Steven Reis
University of Pittsburgh
Clinical and Translational Science Institute

Robert Rizza 
Mayo Clinic College of Medicine
Center for Clinical and Translational Research

Robert Sherwin
Yale University
Yale Center for Clinical Investigation

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.